| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -19% |
| 3Y CAGR | +9% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -98% |
| 3Y CAGR | -1% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,814.00 +3.20 (0.11%) | 21,361.19 | 31.51 | 5.96 | ||
PfizerPFIZER | ₹4,596.50 -13.20 (0.29%) | 21,107.32 | 28.71 | 5.02 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,851.00 -93.00 (1.34%) | 17,327.00 | 102.15 | 19.85 | ||
Natco PharmaNATCOPHARM | ₹838.30 +9.65 (1.16%) | 14,848.21 | 12.97 | 1.61 |